Musk's brain-computer interface company, Neuralink, said Thursday it has received approval from the U.S. Food and Drug Administration (FDA) to launch the first human clinical study of a brain implant.。This is an important milestone and marks the company one step closer to realizing its grand vision of seamlessly connecting humans and machines.。